Anika Therapeutics reported $90.32M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Abbott ABT:US $ 7675M 2124M
Acorda Therapeutics ACOR:US $ 31.87M 13.76M
Agenus AGEN:US $ 247.71M 44.22M
Agios Pharmaceuticals AGIO:US $ 80.03M 123.1M
Anika Therapeutics ANIK:US $ 90.32M 4.06M
Arrowhead Research ARWR:US $ 86.41M 5.18M
Chemocentryx CCXI:US $ 40.58M 9.4M
Clovis Oncology CLVS:US $ 122.24M 21.19M
Enanta Pharmaceuticals ENTA:US $ 40.99M 58.08M
Halozyme Therapeutics HALO:US $ 117.84M 0.88M
Heron Therapeutics HRTX:US $ 56.91M 33.63M
Immunogen IMGN:US $ 437.66M 41.09M
Insmed INSM:US $ 515.7M 201.08M
Integra Lifesciences IART:US $ 407.09M 106.36M
Intrexon XON:US $ 40.32M 2.6M
Johnson & Johnson JNJ:US $ 1579M 322M
Karyopharm Therapeutics KPTI:US $ 153.26M 37.2M
Ligand Pharmaceuticals LGND:US $ 14.99M 4.53M
Macrogenics MGNX:US $ 47.33M 76.14M
Merit Medical Systems MMSI:US $ 53.88M 13.88M
Peregrine Pharmaceuticals PPHM:US $ 149.96M 13.72M
Rigel Pharmaceuticals RIGL:US $ 24.68M 5.79M
Sangamo Biosciences SGMO:US $ 120.26M 58.62M
Stryker SYK:US $ 1458M 1486M
Surmodics SRDX:US $ 24.71M 1.94M
Veracyte VCYT:US $ 163.62M 9.58M
Xencor XNCR:US $ 78.27M 65.21M
Zimmer Biomet Holdings Inc ZBH:US $ 435.8M 42.7M